<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojmp
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Medical Psychology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2165-9370
   </issn>
   <issn publication-format="print">
    2165-9389
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojmp.2025.141003
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojmp-140030
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Management of Borderline Personality Disorder Crises in the Emergency Room: A Case Study
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Taqialdeen
      </surname>
      <given-names>
       Zamil
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Talato
      </surname>
      <given-names>
       Kabore
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ayman
      </surname>
      <given-names>
       Tailakh
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Khadija
      </surname>
      <given-names>
       Hamisi
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aSchool of Nursing, California State University, Los Angeles, USA
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     29
    </day> 
    <month>
     11
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    01
   </issue>
   <fpage>
    32
   </fpage>
   <lpage>
    40
   </lpage>
   <history>
    <date date-type="received">
     <day>
      21,
     </day>
     <month>
      November
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      18,
     </day>
     <month>
      November
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      18,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    This case study describes the care provided to a female patient with borderline personality disorder (BPD) who presented to the emergency department (ED). While people with borderline personality disorder use emergency services frequently, clinicians often face difficulties when providing medical and behavioral services to these patients. It may be difficult for nurse practitioners to determine if a patient with BPD who presents to the ED in crisis should be admitted, medicated, observed, or discharged. Self-harm is frequently confused with suicide attempts, which can result in unnecessary hospitalizations. This case study seeks to examine the proper management and difficulties encountered by healthcare providers in managing crises involving individuals with BPD in ED settings. The case study underscores the significance of thorough evaluation, recognition of BPD characteristics, active engagement in treatment, the therapeutic alliance, and the emphasis on interpersonal connections and stressors alongside the utilization of psychopharmacology.
   </abstract>
   <kwd-group> 
    <kwd>
     Borderline Personality Disorder
    </kwd> 
    <kwd>
      Psychiatric Crises
    </kwd> 
    <kwd>
      Borderline Personality Crises
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Personality disorders are mental health disorders that impair functioning by recurring unhealthy patterns of behavior, thought, and emotion that don’t match society’s expectations <xref ref-type="bibr" rid="scirp.140030-1">
     [1]
    </xref>. There are 10 distinct personality disorders classified by the Diagnostic and Statistical Manual, Fifth Edition (DSM-5) <xref ref-type="bibr" rid="scirp.140030-1">
     [1]
    </xref>. Borderline personality disorder (BPD) is characterized by unstable relationships and dysfunctional mood, affect, reality, and function <xref ref-type="bibr" rid="scirp.140030-1">
     [1]
    </xref>. BPD is not diagnosed until the age of 18 due to specific developmental differences. Due to the nature of symptoms, people with BPD use mental health services heavily and are more prone to attend crisis centers and emergency rooms <xref ref-type="bibr" rid="scirp.140030-2">
     [2]
    </xref>.</p>
   <sec id="s1_1">
    <title>Significance and Prevalence</title>
    <p>Individuals with BPD are more prone to visit the emergency room due to a variety of characteristics including chronic suicidality, self-destructive tendencies, emotional instability, binary thinking, and impulsivity. Elison et al. <xref ref-type="bibr" rid="scirp.140030-3">
      [3]
     </xref> report that 1% of the population has BPD, albeit prevalence varies by locality. BPD affects 20% to 22% of mental health hospitalized patients and 10% to 12% of outpatients <xref ref-type="bibr" rid="scirp.140030-1">
      [1]
     </xref>. Dizygotic twins have a seven percent BPD prevalence, but monozygotic twins have 35%, demonstrating its genetic nature <xref ref-type="bibr" rid="scirp.140030-4">
      [4]
     </xref>. BPD accounts for 9% of mental health crises and 12% to 18% of psychiatric hospitalizations <xref ref-type="bibr" rid="scirp.140030-5">
      [5]
     </xref>. According to Shin et al. <xref ref-type="bibr" rid="scirp.140030-6">
      [6]
     </xref>, 60% to 80% of individuals with BPD attempted suicide. While 8% - 10% of individuals with BPD completed suicide <xref ref-type="bibr" rid="scirp.140030-7">
      [7]
     </xref>. Another BPD symptom is self-harm which about 63% - 80% of patients attempt <xref ref-type="bibr" rid="scirp.140030-8">
      [8]
     </xref> <xref ref-type="bibr" rid="scirp.140030-9">
      [9]
     </xref>. Patients with BPD need more mental health services than the general U.S. population. In general, between 70% to 95% of patients receive psychosocial therapy and 79% may require inpatient care <xref ref-type="bibr" rid="scirp.140030-5">
      [5]
     </xref>.</p>
    <sec id="s1">
     <title>2. Case Vignette</title>
     <p>A 24-year-old woman, with a history of trauma and BPD, presented to the Emergency Department reporting suicidal thoughts and a plan to kill herself by cutting her wrist following a breakup with her boyfriend. The patient had superficial horizontal cute on both forearms. She had been experiencing anxiety and depression symptoms in the weeks leading up to the ED visit. She reported experiencing chronic suicidality but did not have a plan until she had the breakup on the day of ED visit. Her sister, who was present at the Emergency Department described her as “dramatic” and mentioned that she tends to have emotional breakdowns and engage in cutting during periods of stress.</p>
     <p>She was hospitalized 4 times in the past for suicidality. She has recently stopped taking antidepressants due to side effects. She had no significant medical history nor family history. Her immunizations were up to date. The patient has a history of childhood trauma which involved witnessing domestic violence. Her parents separated when she was a teenager. She had multiple relationships in the past, in which she struggled with abusive partners.</p>
     <p>The physical examination revealed small wounds on both forearms but was otherwise normal with no signs of distress. The patient’s vital signs were normal: blood pressure 121/72 mm Hg, heart rate 98 beats/min, respiratory rate 24 breaths/min, oxygen saturation 99% on room air, and oral temperature 37.1 C. The diagnostic tests she received were a complete blood count, metabolic panel, pregnancy test, and urine drug screen. The results of her blood work were normal, and both the urine drug screen and pregnancy tests came back negative. She completed the Adverse Childhood Experience Questionnaire (ACEs) and scored 7. She completed the Colombia Suicide Severity Rating Scale (C-SSRS) and scored 19. In this case, the ED clinician did not utilize the McLean Screening Tool for BPD <xref ref-type="bibr" rid="scirp.140030-10">
       [10]
      </xref> since Amy has already been diagnosed with the disorder. The ED practitioner performed a mental status examination. The patient appearance was appropriate to age, she was agitated, sobbing, which made it harder for her to communicate. She expressed suicidal ideation with a plan to cut her wrist. She was not experiencing any auditory or visual hallucinations and did not exhibit delusional or paranoid thinking. She demonstrated appropriate insight and judgment.</p>
     <p>While some hospitals offer emergency psychiatric care in the ED, these were not offered at this facility. Emergency practitioners, including physicians, nurse practitioners, and physician associates, may have to use their clinical judgment to determine the proper course of action and avoid unnecessary treatments that might negatively affect treatment outcomes. In this case, the ED practitioner conducted an interview and took a history as the patient struggled to communicate. Her sister offered collateral history. The practitioner opted to prescribe Olanzapine 10 mg oral tablet to alleviate agitation.</p>
     <p>The patient was observed overnight and was reassessed in the morning. She was more communicative in the morning and reported feeling better. She denied having suicidal ideations or urges to self-harm. The patient reported that the superficial cuts she inflicted were not an attempt to end her life and explained that cutting makes her feel better and less stressed. She reported receiving dialectical behavior therapy (DBT) in the past but has not had any therapy sessions in the past 2 years. She is currently off medications because they caused her side effects. The patient agreed to enroll in an intensive outpatient program that provides DBT and other clinical services. A safe discharge plan was discussed with the patient and her sister, who agreed to stay with her for the next few days. She was discharged from the emergency department later that day. The patient agreed to enroll in an intensive outpatient program that provides DBT and other clinical services. A safe discharge plan was discussed with the patient and her sister, who agreed to stay with her for the next few days. She was discharged from the emergency department later that day.</p>
    </sec>
   </sec>
   <sec id="s3">
    <title>3. Pathophysiology</title>
    <p>As there is no single cause of BPD, a variety of factors may be involved <xref ref-type="bibr" rid="scirp.140030-4">
      [4]
     </xref>. In recent years, a relationship has been made between the development of BPD and childhood trauma, such as sexual, emotional, and physical abuse. Notably, traumatic experiences in childhood alter the amygdala, prefrontal cortex, and hypothalamus-pituitary-adrenal axis, which increases the risk of developing BPD <xref ref-type="bibr" rid="scirp.140030-4">
      [4]
     </xref>. According to Saccaro et al. <xref ref-type="bibr" rid="scirp.140030-11">
      [11]
     </xref>, depression and anxiety are illnesses that predispose individuals to BPD, therefore they also play a part in the development of BPD. For instance, sadness and anxiety raise neuroendocrine stress, which results in neurotransmitter imbalances and inflammatory reactions that ultimately cause BPD <xref ref-type="bibr" rid="scirp.140030-11">
      [11]
     </xref>. Bøen et al. <xref ref-type="bibr" rid="scirp.140030-12">
      [12]
     </xref> indicated that individuals with BPD had reduced metabolic activity in the brainstem and midbrain, establishing a correlation between declined brain activity in certain regions of the brain and the disorder. According to Nia et al. <xref ref-type="bibr" rid="scirp.140030-13">
      [13]
     </xref>, the genetic factors in the development of BPD are not fully understood, due to the limited scope of research in this area. The limited data suggests multifactor may contribute to the development of BPD including genetic and environmental <xref ref-type="bibr" rid="scirp.140030-13">
      [13]
     </xref>.</p>
   </sec>
   <sec id="s4">
    <title>4. Risk Factors</title>
    <p>Amy has experienced a great deal of trauma throughout her childhood. BPD is complex and is influenced by several risk factors. De Aquino et al. <xref ref-type="bibr" rid="scirp.140030-14">
      [14]
     </xref> highlight sexual harassment and assault, childhood sexual abuse, and adult sexual abuse as potential contributions to the development of borderline personality disorder. Traumatic experiences can disrupt a person’s self-image and relationships, causing instability and impulsivity of patients with BPD. Zanarini et al. <xref ref-type="bibr" rid="scirp.140030-15">
      [15]
     </xref> suggested that childhood abuse and neglect set the stage for emotional dysregulation and relational issues, which increase BPD risk. Psychological factors also play a significant role in the BPD risk profile. Yen et al. <xref ref-type="bibr" rid="scirp.140030-16">
      [16]
     </xref> emphasized the relationship between BPD and concomitant anxiety and depressive illnesses.</p>
   </sec>
   <sec id="s5">
    <title>5. Recognizing the Problem and Diagnosis</title>
    <p>Amy has been dealing with borderline personality traits since her teenage years, and her family has always thought she was quite dramatic. Although general and emergency department practitioners may observe BPD’s maladaptive behaviors, they may fail to recognize them as part of a more complex condition. Anger and mood instability are common in BPD patients during crises. Bipolar and major depressive disorder symptoms may resemble BPD. Trauma and chronic suicidality are significant risk factors of Borderline Personality Disorder <xref ref-type="bibr" rid="scirp.140030-15">
      [15]
     </xref>. In this case study, Amy scored 7 on the Adverse Childhood Experience Questionnaire (ACEs) <xref ref-type="bibr" rid="scirp.140030-17">
      [17]
     </xref> and scored 19 on the Colombia Suicide Severity Rating Scale (C-SSRS) <xref ref-type="bibr" rid="scirp.140030-18">
      [18]
     </xref>. Although the most reliable method for diagnosing BPD is a formal clinical interview based on DSM-5 criteria, emergency department providers may employ the McLean Screening Tool for BPD to assist in identifying various symptoms and guiding the treatment strategy <xref ref-type="bibr" rid="scirp.140030-19">
      [19]
     </xref>. The DSM-5 diagnostic criteria for borderline personality disorder includes nine symptoms, with the diagnosis being granted if five of the nine symptoms are present. Symptoms include frantic attempts to prevent abandonment, unstable relationships, distorted self-image, impulsivity, suicidality &amp; self-harm, mood swings, emptiness, excessive anger, and dissociation <xref ref-type="bibr" rid="scirp.140030-1">
      [1]
     </xref>.</p>
   </sec>
   <sec id="s6">
    <title>6. Crisis Management in the Emergency Department</title>
    <p>Similar to Amy’s presentation, relationship crises, is a common reason that would cause people with BPD end up in the hospital or emergency room due to the severity of symptoms and emotional state <xref ref-type="bibr" rid="scirp.140030-20">
      [20]
     </xref>. Crises involving self-harm, suicidality, violence, and agitation present complex challenges for healthcare professionals and ED staff <xref ref-type="bibr" rid="scirp.140030-20">
      [20]
     </xref>. Hong <xref ref-type="bibr" rid="scirp.140030-2">
      [2]
     </xref> found in his article that unnecessary hospitalizations, ineffective risk assessment, excessive pharmacotherapy use, and volatile interactions occurring with emergency staff are some of the factors that are affecting the treatment outcome of BPD crises in the emergency department. This can be mitigated and requires careful consideration of both immediate and long-term impacts on health. Restoring the individual’s mental state to its pre-crisis balance while preventing lasting negative effects is the top priority in managing these crises <xref ref-type="bibr" rid="scirp.140030-21">
      [21]
     </xref>.</p>
   </sec>
   <sec id="s7">
    <title>7. Appropriate Psychiatric Management of Borderline Personality in the Emergency Department</title>
    <p>The management of borderline personality disorder involves a continuous process in which the individual and their treating clinician collaborate to achieve specific goals. These goals are to foster a supportive environment, establish a healthy professional relationship, and employ therapeutic communication to sustain the professional relationship and prevent transference and countertransference. Gunderson and Links <xref ref-type="bibr" rid="scirp.140030-22">
      [22]
     </xref> outlined the eight elements of effective psychiatric treatment for BPD. 1) Provide psychoeducation; 2) Be proactive, not reactive; 3) Be thoughtful; 4) Establish a relationship that is both real and professional; 5) Communicate that change is anticipated; 6) Foster accountability; 7) Maintain a focus on life outside of therapy; and 8) Be flexible, pragmatic, and eclectic. While the concepts apply to the continuing management of BPD, several of them are also applicable to emergency and crisis management of BPD.</p>
    <sec id="s7_1">
     <title>7.1. Psychoeducation</title>
     <p>Discussing BPD diagnosis, symptoms, and treatment may assist the patient to understand the disorder’s dynamics, and how it may affect their feeling and reaction to stressors. For those without a formal BPD diagnosis, it is vital to teach the patient and their loved ones about the condition and its treatment. Assure the patient that the prognosis for BPD is favorable and that the majority of people with BPD achieve remission, with some even making a full recovery <xref ref-type="bibr" rid="scirp.140030-23">
       [23]
      </xref>. In the case Vignette, Amy’s grasp of the nature of mood changes, emotions, and crises in the context of BPD helped to speed up stabilization, avoid hospitalization, and motivate her to resume therapy.</p>
    </sec>
    <sec id="s7_2">
     <title>7.2. Be Active, Not Reactive</title>
     <p>BPD patients are inclined to be sensitive and reserved. It is essential to make the patient perceive the provider’s presence and involvement in their treatment. Ask about their symptoms, stressors, and therapy. It is crucial to avoid overinvolvement and reactivity, which may result in unneeded treatments and suboptimal treatment outcomes <xref ref-type="bibr" rid="scirp.140030-22">
       [22]
      </xref>. The medical professionals who assisted Amy in this case utilized active listening, conducted a thorough assessment, and made her feel valued. Amy’s perception of being cared for made her more responsive to receiving medications, prevented any escalation during the visit, and inspired her to follow the recommended course of action following discharge.</p>
    </sec>
    <sec id="s7_3">
     <title>7.3. The Therapeutic Relationship</title>
     <p>Individuals with BPD are more likely to have longer and more frequent ED visits, despite the fact that ED visits might be brief. The establishment of a therapeutic relationship with BPD patients and their participation in the treatment plan may aid in the formulation of realistic expectations. Using an authentic style strengthens the therapeutic alliance and enhances the patient’s perception of the provider’s concern <xref ref-type="bibr" rid="scirp.140030-2">
       [2]
      </xref>. The formation of a therapeutic alliance and the discussion of realistic expectations facilitated Amy’s receptiveness to available treatment options, thereby averting unnecessary inpatient service utilization and emphasizing outpatient treatment instead.</p>
    </sec>
    <sec id="s7_4">
     <title>7.4. Focus on Relationships and Stressors</title>
     <p>Relationship instability is the leading cause of mental health crises among those with BPD. Understanding the circumstances preceding the crisis may assist the patient in regulating and organizing their emotions <xref ref-type="bibr" rid="scirp.140030-2">
       [2]
      </xref> <xref ref-type="bibr" rid="scirp.140030-22">
       [22]
      </xref>. Amy’s crisis originated from relationship difficulties that intensified following her breakup with her boyfriend. Facilitating the discussion and comprehending the impact of BPD on relationships may assist Amy in rectifying unhealthy relational patterns from her past, while participation in outpatient psychotherapy could alleviate relational difficulties and help in establishing healthy relationships.</p>
    </sec>
   </sec>
   <sec id="s8">
    <title>8. Psychopharmacotherapy</title>
    <p>While there are no FDA-approved treatments for BPD, numerous psychotropic medications have demonstrated efficacy in the treatment of this condition. Antidepressants, mood stabilizers, second-generation antipsychotics, are often prescribed in the treatment of BPD. Before prescribing, the treating practitioner should weigh the potential benefits and risks of employing any psychotropic medications <xref ref-type="bibr" rid="scirp.140030-24">
      [24]
     </xref>.</p>
    <sec id="s8_1">
     <title>8.1. Psychopharmacology Treatment in the Emergency Setting</title>
     <p>Amy received Olanzapine 10 mg, which is a sedative antipsychotic medication that may help deescalate high levels of agitation and anxiety. Second generation antipsychotics are frequently prescribed to individuals with BPD who present with agitation and/or extreme anxiety to mitigate the risks associated with agitation and severe anxiety <xref ref-type="bibr" rid="scirp.140030-24">
       [24]
      </xref>. Antihistamines and other short-term sedatives are the initial treatment for a BPD crisis if the individual’s presentation is not associated with agitation. This approach has fewer adverse effects, a low potential for abuse, no overdose hazards, and a minimal likelihood of addiction <xref ref-type="bibr" rid="scirp.140030-25">
       [25]
      </xref>.</p>
    </sec>
    <sec id="s8_2">
     <title>8.2. Maintenance Psychopharmacology Treatment</title>
     <p>Treatment for BPD can include selective serotonin reuptake inhibitors (SSRIs) which are often used because they are seen as a safe alternative with few potential adverse effects <xref ref-type="bibr" rid="scirp.140030-26">
       [26]
      </xref>. Other drugs with a low risk of abuse, overdose, or dependency can be used. Serotonin norepinephrine reuptake inhibitors (SNRIs) and atypical antidepressants are regarded as safe maintenance treatment options for BPD. Mood stabilizers, a class of FDA-approved drugs for the treatment of Bipolar Disorder, can be used to address BPD’s mood instability and impulsivity on off label basis <xref ref-type="bibr" rid="scirp.140030-24">
       [24]
      </xref>. The use of Low dose Quetiapine has shown effectiveness in treating BPD symptoms <xref ref-type="bibr" rid="scirp.140030-27">
       [27]
      </xref>.</p>
    </sec>
    <sec id="s8_3">
     <title>8.3. Contraindicated Medications</title>
     <p>Despite conflicting data regarding the pharmacological management of Borderline Personality Disorder (BPD), a recent extensive comparative study determined that benzodiazepines were linked to the greatest risk of attempted or completed suicide compared to other medication classes used in individuals with BPD <xref ref-type="bibr" rid="scirp.140030-28">
       [28]
      </xref>.</p>
    </sec>
   </sec>
   <sec id="s9">
    <title>9. Discussion</title>
    <p>Borderline Personality Disorder (BPD) is a complex mental health condition influenced by various risk factors. Key risk factors include sexual harassment and assault, childhood traits, parental psychopathology, relationship dynamics, co-occurrence with other mental disorders, and coping mechanisms. Understanding and assessing the risk factors is crucial for accurate assessment, early intervention, and effective treatment of individuals at risk of developing BPD.</p>
    <p>Crisis management for individuals with BPD in emergency departments is crucial and the top priority should remain restoring mental state to pre-crisis balance. Effective psychiatric treatment involves developing a healthy professional relationship between the individual and the treating clinician, using psychoeducation, being proactive, being thoughtful, maintaining a real and professional relationship, communicating expectations, fostering accountability, maintaining focus on life outside therapy, and being flexible, pragmatic, and eclectic.</p>
   </sec>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.140030-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, American Psychiatric Association. &gt;https://doi.org/10.1176/appi.books.9780890425596
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hong, V. (2016) Borderline Personality Disorder in the Emergency Department: Good Psychiatric Management. Harvard Review of Psychiatry, 24, 357-366. &gt;https://doi.org/10.1097/hrp.0000000000000112
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ellison, W.D., Rosenstein, L.K., Morgan, T.A. and Zimmerman, M. (2018) Community and Clinical Epidemiology of Borderline Personality Disorder. Psychiatric Clinics of North America, 41, 561-573. &gt;https://doi.org/10.1016/j.psc.2018.07.008
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Anderson, G. (2020) Pathoetiology and Pathophysiology of Borderline Personality: Role of Prenatal Factors, Gut Microbiome, Mu-And Kappa-Opioid Receptors in Amygdala-PFC Interactions. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 98, Article ID: 109782. &gt;https://doi.org/10.1016/j.pnpbp.2019.109782
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Doering, S. (2019) Borderline Personality Disorder in Patients with Medical Illness: A Review of Assessment, Prevalence, and Treatment Options. Psychosomatic Medicine, 81, 584-594. &gt;https://doi.org/10.1097/psy.0000000000000724
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shin, H., Lee, H.S., Lee, B.C., Park, G., Uranbileg, K., Park, Y., et al. (2023) The Prevalence and Clinical Characteristics of Borderline Personality Disorder in South Korea Using National Health Insurance Service Customized Database. Yonsei Medical Journal, 64, 566-572. &gt;https://doi.org/10.3349/ymj.2023.0071
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Penfold, S., Denis, E.S. and Mazhar, M.N. (2016) The Association between Borderline Personality Disorder, Fibromyalgia and Chronic Fatigue Syndrome: Systematic Review. BJPsych Open, 2, 275-279. &gt;https://doi.org/10.1192/bjpo.bp.115.002808
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ruocco, A.C., Rodrigo, A.H., McMain, S.F., Page-Gould, E., Ayaz, H. and Links, P.S. (2016) Predicting Treatment Outcomes from Prefrontal Cortex Activation for Self-Harming Patients with Borderline Personality Disorder: A Preliminary Study. Frontiers in Human Neuroscience, 10, Article 220. &gt;https://doi.org/10.3389/fnhum.2016.00220
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Stoffers-Winterling, J.M., Storebø, O.J., Kongerslev, M.T., Faltinsen, E., Todorovac, A., Sedoc Jørgensen, M., et al. (2022) Psychotherapies for Borderline Personality Disorder: A Focused Systematic Review and Meta-analysis. The British Journal of Psychiatry, 221, 538-552. &gt;https://doi.org/10.1192/bjp.2021.204
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zanarini, M.C., Vujanovic, A.A., Parachini, E.A., Boulanger, J.L., Frankenburg, F.R. and Hennen, J. (2003) A Screening Measure for BPD: The Mclean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders, 17, 568-573. &gt;https://doi.org/10.1521/pedi.17.6.568.25355
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Saccaro, L.F., Schilliger, Z., Dayer, A., Perroud, N. and Piguet, C. (2021) Inflammation, Anxiety, and Stress in Bipolar Disorder and Borderline Personality Disorder: A Narrative Review. Neuroscience &amp; Biobehavioral Reviews, 127, 184-192. &gt;https://doi.org/10.1016/j.neubiorev.2021.04.017
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bøen, E., Hjørnevik, T., Hummelen, B., Elvsåshagen, T., Moberget, T., Holtedahl, J.E., et al. (2019) Patterns of Altered Regional Brain Glucose Metabolism in Borderline Personality Disorder and Bipolar II Disorder. Acta Psychiatrica Scandinavica, 139, 256-268. &gt;https://doi.org/10.1111/acps.12997
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bassir Nia, A., Eveleth, M.C., Gabbay, J.M., Hassan, Y.J., Zhang, B. and Perez-Rodriguez, M.M. (2018) Past, Present, and Future of Genetic Research in Borderline Personality Disorder. Current Opinion in Psychology, 21, 60-68. &gt;https://doi.org/10.1016/j.copsyc.2017.09.002
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     de Aquino Ferreira, L.F., Queiroz Pereira, F.H., Neri Benevides, A.M.L. and Aguiar Melo, M.C. (2018) Borderline Personality Disorder and Sexual Abuse: A Systematic Review. Psychiatry Research, 262, 70-77. &gt;https://doi.org/10.1016/j.psychres.2018.01.043
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zanarini, M.C., Temes, C.M., Magni, L.R., Aguirre, B.A., Hein, K.E. and Goodman, M. (2020) Risk Factors for Borderline Personality Disorder in Adolescents. Journal of Personality Disorders, 34, 17-24. &gt;https://doi.org/10.1521/pedi_2019_33_425
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yen, S., Peters, J.R., Nishar, S., Grilo, C.M., Sanislow, C.A., Shea, M.T., et al. (2021) Association of Borderline Personality Disorder Criteria with Suicide Attempts: Findings from the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-Up. JAMA Psychiatry, 78, 187-194. &gt;https://doi.org/10.1001/jamapsychiatry.2020.3598
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Felitti, V.J., Anda, R.F., Nordenberg, D., et al. (2014) Adverse Childhood Experiences Study Questionnaire. APA PsycTests. &gt;https://doi.org/10.1037/t26957-000
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Posner, K. (2016) Columbia-Suicide Severity Rating Scale. APA PsycTests. &gt;https://doi.org/10.1037/t52667-000
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wang, F., Zang, C., Goodman, M., et al. (2022) Development of a Screening Algorithm for Borderline Personality Disorder Using Electronic Health Records. &gt;https://doi.org/10.21203/rs.3.rs-1350791/v1
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shaikh, U., Qamar, I., Jafry, F., Hassan, M., Shagufta, S., Odhejo, Y.I., et al. (2017) Patients with Borderline Personality Disorder in Emergency Departments. Frontiers in Psychiatry, 8, Article 136. &gt;https://doi.org/10.3389/fpsyt.2017.00136
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Warrender, D., Bain, H., Murray, I. and Kennedy, C. (2020) Perspectives of Crisis Intervention for People Diagnosed with “Borderline Personality Disorder”: An Integrative Review. Journal of Psychiatric and Mental Health Nursing, 28, 208-236. &gt;https://doi.org/10.1111/jpm.12637
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gunderson, J.G. and Links, P.S. (2014) Handbook of Good Psychiatric Management for Borderline Personality Disorder. American Psychiatric Publication. &gt;https://doi.org/10.1176/appi.books.9781615378432
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zanarini, M.C., Frankenburg, F.R., Reich, D.B. and Fitzmaurice, G. (2012) Attainment and Stability of Sustained Symptomatic Remission and Recovery among Patients with Borderline Personality Disorder and Axis II Comparison Subjects: A 16-Year Prospective Follow-Up Study. American Journal of Psychiatry, 169, 476-483. &gt;https://doi.org/10.1176/appi.ajp.2011.11101550
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., et al. (2021) Current Clinical Psychopharmacology in Borderline Personality Disorder. Current Neuropharmacology, 19, 1760-1779. &gt;https://doi.org/10.2174/1570159x19666210610092958
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Besch, V., Debbané, M., Greiner, C., Magnin, C., De Néris, M., Ambrosetti, J., et al. (2020) Emergency Psychiatric Management of Borderline Personality Disorder: Towards an Articulation of Modalities for Personalised Integrative Care. L’Encéphale, 46, 463-470. &gt;https://doi.org/10.1016/j.encep.2020.04.013
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Starcevic, V. and Janca, A. (2018) Pharmacotherapy of Borderline Personality Disorder: Replacing Confusion with Prudent Pragmatism. Current Opinion in Psychiatry, 31, 69-73. &gt;https://doi.org/10.1097/yco.0000000000000373
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Black, D.W., Zanarini, M.C., Romine, A., Shaw, M., Allen, J. and Schulz, S.C. (2014) Comparison of Low and Moderate Dosages of Extended-Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Psychiatry, 171, 1174-1182. &gt;https://doi.org/10.1176/appi.ajp.2014.13101348
    </mixed-citation>
   </ref>
   <ref id="scirp.140030-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lieslehto, J., Tiihonen, J., Lähteenvuo, M., Mittendorfer-Rutz, E., Tanskanen, A. and Taipale, H. (2023) Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide among Persons with Borderline Personality Disorder. JAMA Network Open, 6, e2317130. &gt;https://doi.org/10.1001/jamanetworkopen.2023.17130
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>